Merit Medical’s Fred Lampropoulos Honored by Nasdaq
December 29, 2025
Nasdaq congratulated Fred Lampropoulos, founder and executive chairman of Merit Medical, on receiving the 2025 BioUtah Executive of the Year Award—a distinction reserved for executives whose vision and influence have not only propelled their organizations to sustained success but have also shaped the future of global healthcare.
Congratulations to Fred on receiving the well-deserved BioUtah award, as well as this recognition from Nasdaq!
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
